Cracking the Code on Canine Cancer: ProPetDX’s Groundbreaking Approach to Early Disease Detection

Jordan Tyler: Welcome back to Founders in Focus, where we're taking you behind the scenes with entrepreneurs redefining the future of animal health, agriculture, and food innovation. Over the past few episodes, we've explored the highs and lows of startup life, balancing business with personal challenges, navigating regulatory hurdles, and scaling groundbreaking innovations.

So far, you've heard from three founding teams currently going through the Plug and Play AgTech and Animal Health Accelerator program. And today, we're introducing a new founder and concept to the mix. Preston Williams, chief executive officer and co-founder of ProPetDX, is bringing early cancer detection into focus, leveraging a multi-omic approach and AI powered diagnostics to transform the way we detect and treat disease.

In our companion animals, Preston's journey started with a deeply personal experience that sparked a vision, a future where pet parents and veterinarians have the tools to catch disease earlier, giving their pets the best chance at longer, healthier lives. We'll discuss the science behind ProPetDX, how Preston balances entrepreneurship with family life, share valuable insights for other founders and talk about what the future holds for preventive pet health.

So, whether you're a pet owner, a veterinary professional, an entrepreneur, or just someone fascinated by the intersection of biotech and business, this one's for you.

We're your hosts, Jordan Tyler—

Mark McAllister: —and Mark McAllister—

Jordan Tyler: —and this is Founders in Focus.

So, Preston, thank you so much for joining us today. I know you've spoken with Mark a few times as you traverse the Plug and Play Animal Health Accelerator program, but I'm super excited to meet you and learn more about your background and ProPetDX itself. So, let's start there. Tell us a bit about yourself and how the personal experiences you've dealt with have led you to create ProPetDX.

Preston Williams: Sure. Thanks, Jordan, again, for having me on. I'm really looking forward to our conversation today. And yeah, so my name is Preston Williams. I'm co-founder and CEO of ProPetDX.

shed my graduate work back in: 2017

Right after I defended, actually on a walk, she started to act a little funny. She was young, uh, right around six years old. And, uh, we took her into the vet, and she actually ended up having, uh, advanced cancer. At that point, there was no recourse for treatment. And so, we actually had to let her go within a week of that, that diagnosis.

And so, since then, it had always been sitting in my mind that I wish like as a pet parent that, you know, I could have a way to understand, is my dog happy, healthy? Is there anything I can do to like help make sure that, you know, if a disease pops up, we could like make sure it's addressed when it's treatable or other types of information that I could do to make sure they're living their best life.

And so that's a few years ago, the star is kind of aligned to launch ProPetDX. And since then, we've done some really great science and have shown some really exciting results on some of these early cancers. And as we move forward, we hope to move that into the veterinary clinics where we can help other pet parents know more about their animals. And if there's a disease present, we can help them get their animals treated early.

Jordan Tyler: Yeah. Preventive care is so huge in the pet space right now, so I appreciate you sharing your personal story. I'm so sorry that you had to go through that, but it sounds like you took a really unfortunate event and are turning it around and using it to give other pet parents more information about their pet's health so they hopefully don't have to experience the same thing that you did.

Preston Williams: Yeah, Kipper was her name and she's, you know, she's still right there in my thoughts. And then also what we have our golden retriever right now, her name is Jazz. She's turned in five this year, and then we also have a cat named Pumpkin. So, uh, you know, as when I look to Kipper and her experiences, I hope that empowers us to help Pumpkin and Jazz as well now.

Mark McAllister: Yeah, super cool. Let's narrow in the conversation a little bit. Let's, let's go in and talk about the core technology of ProPetDX. Give us a kind of quick overview, if you could, of the, of the actual product and some of the development on it.

Preston Williams: For sure. Yeah. So, uh, we provide a veterinary diagnostic. It's a blood based, uh, diagnostic test, and the reason we focused on a blood-based diagnostic is that's the location of a lot of really important biomarkers and biomolecules that are found that really reflect that real time health.

And the reason we have chosen blood is when I think about like the body and in disease, right, all of our organs, or if a tumor is there, blood's going to be flowing through all of that. And when a tumor is growing really fast, it actually like leaks a lot of its biological material into that blood. And that is why we think the blood is the perfect place to look to understand if there's like a cancer present.

And it also has a lot of other really key health information. And so, the exact. types of molecules we look at are these biomolecules called proteins. These are the ones doing all the biological tasks in the cells. We also look at lipids and metabolites. And so, we actually measure each one of these individually through our technological platform.

And then at the end we integrate those. And so, this is called like multi omics, meaning that we take. Multiple levels of biology and then connect those dots through our artificial intelligence enabled analysis platform, and then we can really get a good understanding of what's happening from a biological point of view.

Mark McAllister: Yeah, that multi-omic approach, I think, was what interested me the most when we first chatted, which I think was coming up on a year ago. And then obviously you've developed that over the last few months. Why is multi-omics either a better option, the best option, and then maybe a second question on that, what's the underlying innovation behind that?

Or I guess maybe another way of asking that is, compare kind of the multi-omic approach, blood-based approach to what we're typically using in most vet practices today.

Preston Williams: For sure. And, to date, a lot of the really good diagnostics are either classical blood work, um, or they center on like genomic, that DNA information. There's tons of great information that can be gathered from those types of analytes. But the fact that like proteins are the biomolecules doing all those tasks, those really important things in our cells, those are the ones that are going to be thrown out of whack the earliest. And that change is what we're going to be able to see.

And so that's why we've kind of been a protein first company. And, with that, like, why hasn't proteomics kind of like been widely used is that there's a number of really big challenges. And I think that this is where the analytical chemistry, uh, part of my history really comes into play. We wanted to make sure our platform like delivered the highest and most confident level of science. And so, what happens is there's a lot of different things in our blood. You know, there can be tens of thousands of different analytes at any given time. And it's very difficult to measure all of those.

And so, what we've done is we've used this technology that allows us to dive very, very deep inside the, the proteome, all those biomolecules and measure those very reproducibly over time. There's a number of different technologies we use ranging from mass spectrometry to other aptamer based methodologies. And this really allows us to get that global perspective. And so that's one part of the equation. The other part is how do you turn those measurements into something you can use and with all the buzz right in the AI and machine learning spaces and all the power computationally, that's the extra secret ingredient that's like really accelerated it is, now that we have the data, we can measure it. Well, combine that with a really strong computational approach and that is unlocking previously unattainable, like, biological insights.

Mark McAllister: Yeah, our, our ability to parse spectra, just mass spectra data seems like it's increasing on a monthly basis at this point, but very interesting.

Preston Williams: Yeah. And I think the extra part is like being able to like find these changes across these different levels of biology. And that actually tells us a further story, right? So not only are we starting to see which things change with cancer development, we're starting to understand the cancer development biological process better. So, we're going to be able to contribute to the scientific literature, um, to help for further developments on like drugs or other types of treatments while we're really generating a really good diagnostic platform that can bring that value, that knowledge to the pet parents, veterinarians, and even researchers.

Jordan Tyler: Super cool. And I'm really curious to understand, obviously you're in the early cancer detection space specifically right now, but what else might be on the table for this technology? Like how broadly do you believe it can be used to detect other diseases or common conditions and companion animals and maybe even other animals?

Preston Williams: For sure, yeah. And you're dead on, Jordan, that we are a cancer diagnostics—that's what we were founded to do, especially with our history and founding kind of mission. And so those cancers that we look at include lymphoma, hemangiosarcoma, osteosarcoma. These are the three, I would say, biggies in canine cancer.

And the part where we really wanted to enable is something like lymphoma. There's several FDA approved treatments for canine lymphoma. But the hard part is how do you know to deploy that treatment in a time where you could actually see a positive outcome? And so, to see like how far back we can actually look back in time to be like, when can we tell when things are starting to go out of whack?

That's actually kind of like some of our key steps in our discovery studies. What separates us is the way we're building our platform really looks at certain individuals over time. So, we know that some dogs get cancer, but we have samples from them from when they weren't displaying any cancer symptoms.

So, as we start to look back, we can say, Oh, like, is this a year before any physical symptoms or even longer? And so that's our goal is we really want to go well before any physical symptoms happened where a treatment. You know, is more successful and then as an extra benefit, it actually can decrease costs for the owner as well, where I see this going actually further is, you know, as we've mentioned, proteins are really reflective of all the biology that's happening.

And so what other things do I wish I could like talk to my dog to know? And these can span the imagination. So, some of our initial ones, we can actually understand things about like their health state. We can actually understand lean body mass. Does your dog have the lean body mass it needs in order to be active and healthy for the longest time? And as dogs age, that lean body mass may tend to decrease. So our diagnostic can say, Oh, we're seeing a decrease in lean body mass. Maybe this other food choice might be better for the pet parent, independent of any cancer.

We can also look a lot at like kidney health and liver health. So, we can start to like really help the veterinarian kind of have x ray vision into the dog and say, Oh, like all these organs are looking good, or there's no disease, or if the health is looking great, too, we can kind of really inform everyone about that.

So I would say we have cancer, but we also have a very selective set of health endpoints that we're looking at as well.

Jordan Tyler: Yeah, sounds like a lot of potential there. So, super cool. And hearing you talk about that totally reminded me, I was speaking with a veterinarian recently, and one of the things that he said that really stuck with me was, “I wish I had a retrospectoscope,” because then I would know exactly the right thing to do for every sick pet I encountered.

And of course, that's Not how veterinary medicine works, not really how any medicine works, but hearing you talk about this technology almost makes me want to call this guy up and be like, “Hey, remember that retrospective scope you were wanting?” Because really what ProPetDx is going for is the ability to extend that window that we can see into a pet's body.

You know, dogs can't talk. They can't tell us how they feel. But there are clues in their blood and in their bodies that we could be looking for to inform any preventive steps and avoid really devastating outcomes down the road. But now I'm babbling. Mark, do you want to get us back on track?

Mark McAllister: I love that. Shifting back to maybe more of the timeline, I know you've hit a couple milestones, pretty key milestones in the development of the platform. Maybe give us a context, uh, since the beginning, a couple of the, of the biggest hurdles, uh, you've either overcome or a couple of the biggest breakthroughs you've had, uh, with the platform as a way of describing your, your, your journey here.

Preston Williams: For sure. Yeah. I think, uh, this kind of can go into a couple of different directions from like logistical, like startup hurdles to like scientific hurdles. And so, I think maybe on that first part, like startup hurdles is like, you know, when you're going out. It's kind of like, who do I talk to? Um, so it was again, leaning kind of on my network with some folks that I've known for a long time, some of whom are, you know, involved scientifically on our advisory board of ProPetDX to be like, Oh, here's a good person to talk to and have those mentors, especially through those crucial early stages.

This is making sure you're set up for success. So, I think that that's actually a part of the startup, like life cycle that I was like less familiar about right out of the gates, but I knew like one of the best parts were the science was there. Like, I understand the science quite well, and I know there's like information that could help people.

And that was like what the main driver was. So, with that behind us, we were able to push through those like initial steps. The hardest part when you're early, right? Is two things. It's getting samples that you can run to make sure you can develop your tests. And number two is funding, right? So, we were able to, like, have conversations with some really well known veterinarians and be able to get samples to, like, demonstrate the power of our platform.

And that was one of the special things in science and startup life that you love is, you know, we have this idea We worked hard to get these samples, we bootstrapped through some fundraising and, and then we complete a study and you say, wow, there's actually really difference between someone with a cancer and another dog that, you know, is healthy at the same age.

And that was like, that's the best part of it all. So now, since then, like, how do you go from that smaller study into something that's statistically powered enough to that you can deploy a product that's a whole different set of challenges. And so that's what we've been kind of working through. And some of the milestones we've hit include like getting our larger biobank that now is statistically powered.

So now we have samples that can validate our initial findings. And then also like making sure that we have connections with the right set of individuals and even some veterinarians that are like, “Hey, we,” you know, “we're interested in deploying the initial stages of product when we get there.” So that's kind of where the milestones are and it's just a fun ride.

Mark McAllister: All right. So, I think we'll shift the conversation a little bit. Since September of last year, we've gotten the opportunity to work with you as part of the Plug and Play Animal Health Accelerator program. Tell us a little bit about your experience with the accelerator, some of the things you've been able to do so far, and then yeah, how that's impacted how you've run ProPetDX.

Preston Williams: For sure, yes, um, you know, acceptance into the Plug and Play Accelerator program was a key event, I would say, in ProPetDX’s arc. It provides such a, like, a unique area where I can not only have, like, connections with key folks in the field and get different ideas, but it also, like, helps me, like, build out different parts of the planning to make sure that we're, we're on a path to have, like, measurable achievements that can demonstrate value, which then lead to, like, the various levels of investment.

Investing in the veterinary space is kind of more challenging, and in order to get these like larger sets of money that is needed to develop a diagnostic, you really need to have a great track record. Plug and Play not only allows me to again, talk to the right folks. I now have like a much better understanding of like various details in the veterinary community that we were trying to address.

So that knowledge and then the like infrastructure around Plug and Play is really like, again, done exactly what the name says. It'd be accelerator program. I guess I didn't realize how hard we were going to hit the accelerator, but it's been great. And just in the first several months, I think that that's why we've been able to hit these like milestones of getting access to this and, you know, bringing in this money and having these extra advisors are on our board. It's just been such a good thing for us.

Mark McAllister: Well, obviously we're really excited to bring that exposure to all of our startups. I really appreciate that. And yeah, we're, we've been really excited to work with you again, just highlighting. Like you say, we love working with folks like yourself who are either pre commercialization or early commercialization, and then giving you a tool chest of opportunities to develop that into something that hits the market. So.

Preston Williams: Yeah, for sure. The other aspect I want to highlight too is like, you know, we came in very, you know, companion pet centric. This is dogs. We eventually want to go to cats is our next endpoint. And then horses after that.

But being in the animal health and ag tech vertical, I've interacted with folks from the agriculture space and they're like, have you looked at maybe potentially using this for like, herd level population? You know, screening and understanding, and so there's this whole extra addressable markets that we now have in our heads, kind of figuring out like, “Oh, how could we do that?” And so, expanding our reach, solving good problems in multiple, like parallel verticals, is really just incredible.

Jordan Tyler: That's great to hear. You've had some interesting conversations and unexpected opportunities based on your exposure to the plug and play ecosystem. So that's awesome.

Now, taking a bit of a turn here, but whenever I speak with entrepreneurs, particularly young ones like yourself, I'm always curious about how they structure their personal lives around Seems like a Herculean task of running a startup. And so, what does that look like for you? How do you balance the demands and joys of family life with the demands and joys of startup life?

Preston Williams: Yeah, so with founding and balancing a family, you know, especially so myself, I have two young kids. We have a seven-year-old and a four-year-old. I actually think that in a way that it's an advantage, oddly enough. And I think that that's because it, it kind of forces you to take one step away to focus on that.

So, I really try to make sure that I'm, when we go to events with our kids—or today is a Friday, and so we have our board game. So, we're going to be playing mousetrap later with them with all like electronics off. Right? So, when you have that, like, time to balance, when you come back into it, I feel like very refreshed. So, you know, I just come at these problems from a different perspective when you actually think through them and take a step from like the grind. I actually think that that is really very, very important. And so, yes, a balance is key.

Mark McAllister: I love that. I have not heard a founder describe it. As such, I think they would all refer to it in a similarly positive way. Uh, but I, I like that framing on it's a family is a, is a reprieve and a reset that allows you to perform at a higher level at the company. I love that.

Staying on the personal relationship side, obviously as in startup life, you have to build this team, build this set of humans that are highly aligned around a vision, which can be challenging, can be a real struggle for some companies. Give us a personal lesson you've learned working with peers on the startup side.

Preston Williams: Yeah, I think, uh, building an advisory board, this is people you have talked with, interacted with for a while, you know, everyone in the group seems to have like really similar, like goals and focuses, and then it kind of naturally comes and so. One of ProPetDX's strongest traits is our scientific advisory board.

Our advisory board is actually expanding by two members right now, so it'll be six people totally. Each person provides such key value, like, uh, one of our advisors, just to highlight, um, his name is Nathan Price. He's the co-director of aging at the Buck Institute. But Nathan's been really great in that, you know, he provides really key information. He's an aging expert—longevity is another thing that we're keen on focusing on for the animal space. He brings computational expertise and that complements another advisor. Um, his name is Paul Kearney. He specializes in moving things from like a research phase into like more of a product. And so, like, you can see that each one of these, these members of an advisory board fill in a key gap that I might not have expertise in.

And where do those come from? That's been years of building of reaching out and networking and just like asking the questions like, “Hey, like we're, we're starting an animal health company. Let me chat with you for 10 minutes,” and then following up a few weeks later.

To compliment this is like, even if you really want someone, if they're not aligned or not like into it, it's better to just be friends and cordial and, and good and, and not have them on, on, even if you really would like them to be part of this. I think that making sure they're fully bought in is something that's really key. And that actually, I think goes for investors as well. You know, sometimes like you can be so focused on like, how do I like, close this deal? How do I bring this person on so we can like achieve this? But if it's not exactly right, that relationship can get, you know, it can just cause like unnecessary pinch points.

And so, like, being confident enough to be like, it's okay. You know, we wish you well, you're going to do great in your aspect and ProPetDX is going in on their path. That's also another thing I think is understood. Like it's okay to say no. And finding the right partners is just very, very important, both advisory board level, board of director level, and investor level.

Mark McAllister: You know, this is a consistent theme across most of industry, but unfortunately it just takes time. It takes time to develop that. It takes a couple of mistakes here and there. Maybe just a fair warning to the early entrepreneur, it takes time, and there's no experience like personal experience.

Preston Williams: Yeah. And sometimes like when you do have those like bumps in the road, I think that that's like a part where you can like start to like question, like, is my idea, like actually going to move the needle? Is it really what I think it is? And to be able to like, look at the data, which is what we do, like all day long and be like, yeah. We have a great accelerator program. We have a great advisory board who are all like cheering you on and you're like, you know, just look at the data. You're doing well. There's going to be bumps. It's okay. Keep going.

Jordan Tyler: Rolling with the punches and taking them as learning opportunities rather than reasons to throw in the towel.

I think that's a great message and I'm sure a lot of other entrepreneurs would resonate with that as well. And kind of brings me to my next question. I can't believe I hadn't asked you this already, but is this your first time running a startup or have you previously been an entrepreneur?

Preston Williams: I've never been an entrepreneur before. This is my first startup. I've worked in startups before, but, uh, you know, more like as an employee versus like a founder, and it's just a very different set of hats you have here, which is part of the fun actually.

Jordan Tyler: Yeah, yeah, I loved your advice on, you know, even when it gets bumpy, just come back to your why, come back to the data, the proof in front of you of why this could work and just keep going.

Do you have any other advice that you would maybe give to other first-time entrepreneurs? You know, lessons that you've had to learn throughout this process? Anything that you would, you know, if you bumped into another aspiring entrepreneur on the street, what would you grab them and shake sense into them about?

Preston Williams: I think it'd be really like refining what you want to do and make sure that that market is there, that the need is there. You're not kind of creating, you know, a solution to like that problem that's not there yet, but like you're actually addressing something that could really help people immediately.

The other thing that I would tell, like, myself, like, and other founders is to keep the optimism, like, I feel like I'm an optimistic person anyway, but there's times where, like, there are those bumps in the road that make you feel like it's a little bit more of a struggle to, to get through and just to know that, like, you know, the science or the efforts that you're doing are so worth it.

And to keep that, and then also to put yourself in those situations to meet new people, expand outside that comfort zone and talk to people in the field and people you wouldn't normally connect with, whether that's through like applying through the Plug and Play accelerator or other incubators or anything else. I think that those are the things that I would go back and tell myself to make sure you do, because those were some of the best and most fun aspects there too.

This is kind of like a funny thing that I have, like, really embraced. I find, like, when I can turn off my notifications, put my phone to the other room, take my watch off, I put my headphones on, but the headphones are connected to a cassette tape. I find that that really helps me because, like, first, I didn't realize, like, a lot of modern artists still release cassettes. Green Day, Blink 182, they have cassettes for sale on their most recent albums. But it's, like, 30 minutes—before I have to flip the cassette—of like uninterrupted focus time. And that really helps me like get these sprints of stuff done, regardless of all the noise of like happening around you or what the pile of emails. I'm doing 30 minutes and then you can like flip the cassette, do that again, when you can. I think that that's like really good, those like quick sprints of productivity really add up over time.

Jordan Tyler: Okay, well now I have to ask, what cassette do you have in there right now?

Preston Williams: It's Green Day's new album. Green Day is like the sweet spot of my high school time. So, it's that. Enemy of the State from Blink 182 is also in the stack right there. I also have some weird ones. This could probably go on for a very long time, but there's some interesting ones. Marty Robbins’ Gunfighter Ballads. That's a weird one, but it's also quite good. So highly recommend that.

Jordan Tyler: Okay, it's kind of giving Buster Scruggs vibes, and I loved that, so I'm totally going to check it out.

Preston Williams: Yeah, yeah, it's, it's good stuff.

Mark McAllister: This is hilarious, I, I love knowing that the secret to the success of a startup is a Sony Walkman from, you know, 30 years ago. This is incredible.

he, the one I have is made in: 1986

Mark McAllister: So that was my follow up. No kidding. Same player, huh?

Preston Williams: Yeah. Yeah. So, it's got the, I only had to replace one of the, uh, bands in the back, which are, are actually really easy to replace. So, we just fixed that one up and it works like a champ.

Mark McAllister: This may take the cake for the most interesting personal bit for many of our founders, I'm going to stow this one away.

Preston Williams: Yeah, for sure. I think the actual impact on like my productivity was much higher than I anticipated. My wife definitely was like… I don't know. And then she's like, “Oh, it actually is like pure focus time.” Like, it's like a signal to switch it on and it just feels good.

Mark McAllister: Maybe we can close out some of the conversation here. Let's talk to the future of animal diagnostics or maybe even just centering on, on pet diagnostics, but give us the forecast over the next five years. Maybe it's the next decade. What do you anticipate as maybe a seminal moment as a part of that is ProPetDX at the at the heart of that shift?

Preston Williams: I think the next several years of veterinary medicine is going to just be so exciting. I envision a pet parent being given a like personalized pet report of like, I like to think of it as like a high-definition health screen where you get a list of things that are measured within your dog, cat, horse or beyond of that says like, “Are any of these key cancers detected?” And you can say none are detected. Oh, that's like a great peace of mind.

Then you can also get this next set of information on like, not only is nothing wrong with them, how can you make them the happiest, healthiest dog or cat possible when you have like that dialed in for you specifically? That is going to be so incredible and it's going to lead to like, longer lives as well, like these animals that have this like great monitoring is going to be really special.

And so, we envision our product to kind of be part of your annual health exam. The vet is going to do blood work. We're going to be just part of the blood work panel, and you're going to get the report that's going to get the report and it's going to be enlightening.

Jordan Tyler: Yeah. So that's kind of the long-term vision. Super good to know. I'm also curious, though, to understand what your end game is for ProPetDX. So, some people, they start a company, they Get as much funding as possible, and then they sell it off and move on others. You know, they stay on a little bit longer. Some even stay with the company well into it being fully scaled and profitable.

So, I'm just curious how you're feeling as a first time entrepreneur. Have you been bitten by the bug? And now you're itching for your next venture? Or are you more hoping to really see this through? And I think I know the answer based on just the conversations that we have had today, but what are your thoughts?

Preston Williams: Great question, and the answer is: I love this science and I think that this science is going to be the one I want to be with for a long time. When you start to think about like the end game like strategy or where we want to go eventually, I think that whether that's an exit to a larger company, you know, that might provide the resources to be able to let us achieve these goals faster.

ProPetDx was founded, you know, with a mission to like empower pet parents and veterinarians to make these really personalized health decisions. You know, we're moving in that direction anyway right now, and I think that there's going to be clear demonstration of that. If there comes a fork in the road down the line that says, “Hey, going in this direction and maybe becoming part of this other organization can let us achieve that better and faster.” That'll make sense then. If it's the other way where it's the best for us to scale and do it ourselves, that's going to work as well. Like, I think we're going to be very centered on our mission and whatever lets us achieve that. The best is what we're going to do.

And I think the other part, and this is kind of one of those things is like, even tonight, you know, when we're playing the board game and I look at our Jazz or Pumpkin or dog or cat, and like, I kind of wonder, you know, they act happy and healthy, are they really happy and healthy? And when I look at them, you know, knowing that we're so close to being able to give you an answer to that, I think that that's what's driving ProPetDX right now is every time I look at our animals. That is what drives me each day and everyone, like all pet parents and veterinarians, is like unlocking that unspoken communication.

Jordan Tyler: Totally. Well, you have a really, really cool vision and are just generally a joy to chat with. So, thank you so much, Preston, for joining us today and letting us pick your brain and ask some personal questions as well as pull back the curtain on ProPetDX. This has been really great.

But before we wrap up, Preston, how can listeners get ahold of you or learn more about ProPetDX and kind of follow along in your journey?

Preston Williams: For sure, yeah. So, I don't have like a TikTok right now. That's actually soon. So, I think it's through our website, www.propetdx.com. I highly encourage everyone to check out our website. I think it really has a nice layout of our technology, what we're doing, who's involved. And there's also a place where you can, you know, sign up for our update emails where you share resources. I like to kind of like bring people along for the ride and to say, “Hey, this month we did X, Y, Z. That's great. And next month is this.” Please, please follow along.

And then also me personally through my email is totally a great one, which is easy: preston.williams@propetdx.com.

Jordan Tyler: Fabulous. We have added links to the ProPetDX website, as well as Preston's personal email, which he was so kind to share, in the show notes for this episode. So, if you're curious, want to learn more, definitely go check that out.

It's safe to say I'm even more excited now for the Plug and Play June Expo in Topeka, so that I can meet Preston in person, and maybe I'll bring my speaker and we can jam to some Blink 182 together. Jokes aside, Preston's journey is truly a testament to the power of turning personal loss And it's so exciting to hear how his work is shaping the future of preventive pet care.

In addition to all that, tons of great advice for other founders¬—some of it probably unexpected with the whole cassette tape thing—on how to carve out focus time and, understanding the nuances of assembling the right advisor, team, and investors. So, we hope that's something every founder can learn from.

To all our listeners, thank you for tuning in today. If you enjoyed this episode, be sure to subscribe, leave us a review, and share the episode with a fellow entrepreneur or pet lover. We've got more incredible disruptors coming your way soon, so be sure to stay tuned.

Until then, remember—every breakthrough has a unique beginning, and behind every founder is a story worth hearing. We'll see you next time.